Results 261 to 270 of about 66,822 (310)

New strategies for the synthesis of functionalized substituted bisphosphonates: chemistry and biological activity

, 2012
I Mulani, Giovanni Sindona, Bartolo Gabriele, Roberto Bartolino   +3 more
openalex   +1 more source

Incidence and Characteristics of Hospital‐Acquired Pressure Injuries in Acute Palliative Care Patients: A Four‐Year Analysis

Journal of Clinical Nursing, Volume 35, Issue 1, Page 255-267, January 2026.
ABSTRACT Aim To describe the cumulative incidence and characteristics of hospital‐acquired pressure injury in acute palliative patients. Design Secondary data analysis of hospital‐acquired pressure injuries during 2019–2022. Methods The setting was a palliative care unit at a tertiary hospital in Queensland, Australia, including adult (≥ 18 years ...
Saroeun Ven, Michael Steele, Adam Burston, Paul Fulbrook, Josephine Lovegrove, Sandra Miles, Susan Prince   +6 more
wiley   +1 more source

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta. [PDF]

Calcif Tissue Int
Hald JD, Weir C, Keerie C, Dewar L, MacLean M, Milne L, Keen R, Walsh J, Poole K, Langdahl B, Lindsay JR, Ghouri N, Hollick RJ, Aspray T, Crowley RK, Cohen-Solal M, Hassan-Smith Z, Tuck S, Curtis E, Harvey N, Eekhoff EMW, Feenstra J, Hampson G, Stone M, Turton J, Patel P, Siddiqi M, Munro R, Roy M, Paskins Z, Narayanan D, Malcolm E, Javaid MK, Osborne P, Tang JCY, Lam W, Moore D, Black HA, Duckworth AD, Makaram N, Guo T, Stenhouse G, Ralston SH.   +42 more
europepmc   +1 more source

Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis A new-user, active comparator design with instrumental variable analyses [PDF]

Ryoji Tominaga, Tatsuyoshi Ikenoue, Ryosuke Ishii, Kakuya Niihata, Tetsuro Aita, T. Okuda, Sayaka Shimizu, Masataka Taguri, Noriaki Kurita   +8 more
openalex   +1 more source

Serum miR-146a as a diagnostic and predictive biomarker for osteoporosis and bisphosphonate treatment efficacy. [PDF]

Am J Transl Res
Yin Q, Yang R, Yu H.
europepmc   +1 more source

Strategies for the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ): An Umbrella Review. [PDF]

Cureus
Gharibi A, Essadeq Z, Yamine H, Al Jalil Z, Kissa J.   +4 more
europepmc   +1 more source

The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose. [PDF]

Osteoporos Int
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM.   +5 more
europepmc   +1 more source

Bisphosphonate-associated jawboneosteomyelitis: Clinical, radiological andhistological features

, 2006
Alberto Bedogni, Giorgia Saia, Luigi Chiarini, P. F. Nocini   +3 more
openalex   +1 more source

Long-Term Follow-Up of a Patient with McCune-Albright Syndrome: A Case Report. [PDF]

J Clin Med
Shoji Y, Kusaka S, Kawashima K, Hamaguchi S, Tachikake M, Akitomo T, Nomura R.   +6 more
europepmc   +1 more source

Rhetoric, evidence and policymaking: a case study of priority setting in primary care [PDF]

, 2009
Greenhalgh, T., Russell, J.
core